Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1742-4933-2-7.

Title:
Roy Walford and the immunologic theory of aging | Immunity & Ageing
Description:
Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Non-Profit & Charity

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure how the site profits.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {πŸ”}

article, cell, roy, google, scholar, walford, cas, pubmed, ageing, human, research, immune, effros, senescence, cells, aging, immunosenescence, replicative, role, exp, hayflick, vitro, immunity, access, contributions, areas, gerontol, open, april, gerontological, normal, studies, privacy, cookies, function, journal, important, death, major, gerontology, immunological, immunology, system, roys, potential, lymphocytes, jexger, science, content, personal,

Topics {βœ’οΈ}

article download pdf open access article cell-specific growth factor clinical correlations remain privacy choices/manage cookies perillo nl edwin cooper expressed disease patients show mech ageing dev article effros provided clinical validation tumour-specific cytotoxic vitro invariably undergo european economic area amyotrophic lateral sclerosis eminent nobel laureate mhc class ii evolutionarily-conserved link seemingly unlimited growth cumulative population doublings swedish geriatric population includes high proportions lack cd28 expression david geffen school current gerontological research replicative senescence research conditions privacy policy understanding antigen presentation find karyotypic abnormalities body temperature reduction references dausset cell cultures analyzed immune risk profile merrit alloantigen system modern immunological approaches 'immunological risk phenotypes' effros rb highly creative aspects replicative senescence arose hayflick limit lead human lymphocytes cultured analyzed cell populations immunology papers describing accepting optional cookies exp cell res cell replicative senescence insightful predictions made established long ago elegans daf-2 mutants annu rev immunol

Questions {❓}

  • Effros RB, Pawelec G: Replicative senescence of T lymphocyte:Does the Hayflick limit lead to immune exhaustion?
  • Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, Wikby A: Is immunosenescence infectious?
  • Pawelec G, Ouyang Q, Colonna-Romano G, Candore G, Lio D, Caruso C: Is human immunosenescence clinically relevant?
  • The human immunosenescence phenotype: does it exist?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Roy Walford and the immunologic theory of aging
         description:Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
         datePublished:2005-04-25T00:00:00Z
         dateModified:2005-04-25T00:00:00Z
         pageStart:1
         pageEnd:3
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1742-4933-2-7
         keywords:
            Ageing
            Immunity
            Immunosenescence
            Walford
            Immunology
            Geriatrics/Gerontology
            Aging
            Public Health
            Clinical Nutrition
            Antibodies
         image:
         isPartOf:
            name:Immunity & Ageing
            issn:
               1742-4933
            volumeNumber:2
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rita B Effros
               affiliation:
                     name:David Geffen School of Medicine at UCLA Los Angeles
                     address:
                        name:Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Roy Walford and the immunologic theory of aging
      description:Roy Walford died on April 27, 2004, at the age of 79. His contributions to gerontological research in such diverse areas as caloric restriction, genetics of lifespan, immunosenescence, DNA repair and replicative senescence were truly remarkable in their depth and innovation. Significantly, most of the areas that he pioneered during his illustrious research career remain the "hot" areas of current gerontological research. In this sense, he has achieved the most important type of immortality. His death was a major personal and professional loss to numerous scientists within the gerontological community. In launching this new journal on Immunity and Ageing, it is highly fitting, therefore, to remember him on the anniversary of his death by briefly reviewing the contributions of Roy Walford to this important facet of gerontology. Indeed, it was Roy who actually first coined the commonly used term "immunosenescence".
      datePublished:2005-04-25T00:00:00Z
      dateModified:2005-04-25T00:00:00Z
      pageStart:1
      pageEnd:3
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1742-4933-2-7
      keywords:
         Ageing
         Immunity
         Immunosenescence
         Walford
         Immunology
         Geriatrics/Gerontology
         Aging
         Public Health
         Clinical Nutrition
         Antibodies
      image:
      isPartOf:
         name:Immunity & Ageing
         issn:
            1742-4933
         volumeNumber:2
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rita B Effros
            affiliation:
                  name:David Geffen School of Medicine at UCLA Los Angeles
                  address:
                     name:Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Immunity & Ageing
      issn:
         1742-4933
      volumeNumber:2
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:David Geffen School of Medicine at UCLA Los Angeles
      address:
         name:Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rita B Effros
      affiliation:
            name:David Geffen School of Medicine at UCLA Los Angeles
            address:
               name:Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, USA

External Links {πŸ”—}(90)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.49s.